Literature DB >> 17357086

Germline mutation of INI1/SMARCB1 in familial schwannomatosis.

Theo J M Hulsebos1, Astrid S Plomp, Ruud A Wolterman, Els C Robanus-Maandag, Frank Baas, Pieter Wesseling.   

Abstract

Patients with schwannomatosis develop multiple schwannomas but no vestibular schwannomas diagnostic of neurofibromatosis type 2. We report an inactivating germline mutation in exon 1 of the tumor-suppressor gene INI1 in a father and daughter who both had schwannomatosis. Inactivation of the wild-type INI1 allele, by a second mutation in exon 5 or by clear loss, was found in two of four investigated schwannomas from these patients. All four schwannomas displayed complete loss of nuclear INI1 protein expression in part of the cells. Although the exact oncogenetic mechanism in these schwannomas remains to be elucidated, our findings suggest that INI1 is the predisposing gene in familial schwannomatosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17357086      PMCID: PMC1852715          DOI: 10.1086/513207

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

Review 1.  The SWI/SNF complex--chromatin and cancer.

Authors:  Charles W M Roberts; Stuart H Orkin
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

Review 2.  A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance.

Authors:  E Nagy; L E Maquat
Journal:  Trends Biochem Sci       Date:  1998-06       Impact factor: 13.807

3.  Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene.

Authors:  M D Taylor; N Gokgoz; I L Andrulis; T G Mainprize; J M Drake; J T Rutka
Journal:  Am J Hum Genet       Date:  2000-03-14       Impact factor: 11.025

Review 4.  Schwannomatosis: a clinical and pathologic study.

Authors:  M MacCollin; W Woodfin; D Kronn; M P Short
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

5.  Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation.

Authors:  Kristin Janson; Lucien A Nedzi; Odile David; Marshall Schorin; John W Walsh; Meena Bhattacharjee; Gabriella Pridjian; Lu Tan; Alexander R Judkins; Jaclyn A Biegel
Journal:  Pediatr Blood Cancer       Date:  2006-09       Impact factor: 3.167

6.  Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.

Authors:  L B Jacoby; D Jones; K Davis; D Kronn; M P Short; J Gusella; M MacCollin
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

7.  Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.

Authors:  J L Rutkowski; K Wu; D H Gutmann; P J Boyer; E Legius
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

8.  Somatic instability of the NF2 gene in schwannomatosis.

Authors:  David L Kaufman; Bianca S Heinrich; Christine Willett; Arie Perry; Frederick Finseth; Raymond A Sobel; Mia MacCollin
Journal:  Arch Neurol       Date:  2003-09

9.  Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.

Authors:  Alexander R Judkins; Joanne Mauger; As Ht; Lucy B Rorke; Jaclyn A Biegel
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

10.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

View more
  115 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

2.  Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with "neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation.

Authors:  Jodi M Carter; Carolyn O'Hara; George Dundas; Dawna Gilchrist; Mark S Collins; Katherine Eaton; Alexander R Judkins; Jaclyn A Biegel; Andrew L Folpe
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

3.  Identification of a novel germline SMARCB1 nonsense mutation in a family manifesting both schwannomatosis and unilateral vestibular schwannoma.

Authors:  Jian Wu; Mingxiang Kong; Qing Bi
Journal:  J Neurooncol       Date:  2015-09-05       Impact factor: 4.130

4.  Reply to: Familial syndromes associated with intracranial tumours: a review.

Authors:  Fonnet E Bleeker
Journal:  Childs Nerv Syst       Date:  2015-08-09       Impact factor: 1.475

Review 5.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

6.  Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters.

Authors:  Michael Y Tolstorukov; Courtney G Sansam; Ping Lu; Edward C Koellhoffer; Katherine C Helming; Burak H Alver; Erik J Tillman; Julia A Evans; Boris G Wilson; Peter J Park; Charles W M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-30       Impact factor: 11.205

7.  Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.

Authors:  Francois Le Loarer; Lei Zhang; Christopher D Fletcher; Agnes Ribeiro; Samuel Singer; Antoine Italiano; Agnes Neuville; Aurélie Houlier; Frederic Chibon; Jean-Michel Coindre; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2014-03-03       Impact factor: 5.006

8.  Rapid detection of SMARCB1 sequence variation using high resolution melting.

Authors:  Vinod Dagar; Chung-Wo Chow; David M Ashley; Elizabeth M Algar
Journal:  BMC Cancer       Date:  2009-12-13       Impact factor: 4.430

9.  Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.

Authors:  Georgette N Jones; Chhavy Tep; William H Towns; Georgeta Mihai; Ian D Tonks; Graham F Kay; Petra M Schmalbrock; Anat O Stemmer-Rachamimov; Sung Ok Yoon; Lawrence S Kirschner
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

10.  What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers.

Authors:  Joseph L Kissil; Jaishri O Blakeley; Rosalie E Ferner; Susan M Huson; Michel Kalamarides; Victor-Felix Mautner; Frank McCormick; Helen Morrison; Roger Packer; Vijaya Ramesh; Nancy Ratner; Katherine A Rauen; David A Stevenson; Kim Hunter-Schaedle; Kathryn North
Journal:  Am J Med Genet A       Date:  2010-02       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.